Definition: A compounding pharmacy makes a medicine from raw ingredients for a specific patient, rather than dispensing a factory-made, FDA-approved product. FDA says compounded drugs are not FDA approved, meaning FDA does not check their safety, effectiveness or quality before they are sold. Compounded semaglutide is a well-known example.
Most compounding pharmacies work under section 503A of federal drug law: a licensed pharmacist in a state-licensed pharmacy (or a licensed physician) compounds a drug for an identified patient based on a valid prescription. Some instead register with FDA as outsourcing facilities under section 503B, which have stricter rules. The differences are covered in 503A vs 503B.
Raw drug ingredients used by a 503A pharmacy must meet a USP monograph if one exists, come from an FDA-registered maker, and come with a certificate of analysis (21 USC 353a).
Compounded products often come in a vial with a concentration, not a pen with set doses. That means you draw by syringe units and do the math. FDA has received reports of people hurt by dosing errors with compounded GLP-1 drugs, some from patients measuring the wrong amount and some from health care workers miscalculating.
From label to syringe
Dose Track saves each vial with its concentration, so the app can convert units to mg using the vial you are actually drawing from.
Read more on Dose Track: GLP-1 units guide · U-40 vs U-100 syringes